Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



DAVIS STEPHEN Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Exercised 103,999 shares @ $0
Sold 51,563 shares @ $21.96, valued at $1.1M
Exercised 103,999 restricted stock units @ $0
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 16,498 shares @ $25, valued at $412.5k
Sold 55,104 shares @ $25.0517, valued at $1.4M
07/13/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 295,503 options to buy @ $21.75, valued at $6.4M
Granted 89,564 restricted stock units @ $0
05/02/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 7,806 shares @ $21.18, valued at $165.3k
Exercised 15,625 restricted stock units @ $0
02/27/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 3,851 shares @ $18.78, valued at $72.3k
Exercised 10,945 restricted stock units @ $0
01/10/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 3,904 shares @ $17.1303, valued at $66.9k
Exercised 9,528 restricted stock units @ $0
01/05/2023 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 74,739 shares @ $0
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2022 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 43,400 shares @ $0
06/16/2022 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Granted 15,000 options to buy @ $1.11, valued at $16.7k
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2022 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 237,931 options to buy @ $25.75, valued at $6.1M
Granted 69,333 restricted stock units @ $0
Granted 277,331 restricted stock units @ $0
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2022 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 3,718 shares @ $23.05, valued at $85.7k
Exercised 9,527 restricted stock units @ $0
01/06/2022 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 18,715 restricted stock units @ $0
12/23/2021 4 DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 10,452 shares @ $0
Granted 20,903 options to buy @ $9.81, valued at $205.1k
10/19/2021 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 2,963 shares @ $17.41, valued at $51.6k
Exercised 5,938 restricted stock units @ $0
07/07/2021 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Granted 6,500 options to buy @ $3.05, valued at $19.8k
04/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 3,000 shares @ $0
Granted 18,000 options to buy @ $19.46, valued at $350.3k
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2020 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Granted 6,500 options to buy @ $8.42, valued at $54.7k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/01/2020 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 6,770 shares @ $49.21, valued at $333.2k
Exercised 15,625 restricted stock units @ $0
04/17/2020 4 DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 1,426 options to buy @ $14.44, valued at $20.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy